Global point of care
Healthcare teams are under intense pressures, which may be heightened by an influx of COVID-19 and flu patients. A patient stratification strategy including the i-STAT System can help you rapidly assess patients, quickly prioritize resources, and continue to deliver the highest quality care.
Healthcare teams are under intense pressures, which may be heightened by an influx of COVID-19 and flu patients. A patient stratification strategy including the i-STAT System can help you rapidly assess patients, quickly prioritize resources, and continue to deliver the highest quality care.
Envision your ED performing at the highest possible level. Whether you're focused on supporting high-quality care, driving operational efficiency, or reducing overall cost of care, helping you achieve your greatest goals is our highest priority.
Explore each patient type or click on a test cartridge for product details.
Representing 9% of all non-injury ED visits, abdominal pain is the single most common complaint in the ED.2
Expediting diagnostic testing supports reduced turnaround time to help alleviate bottlenecks and treatment delays.
With sepsis patients, every minute matters. Accelerate sepsis response in your ED with fast, accurate results at the point of care.
Chest pain patients represent a diagnostic dilemma for the ED. Fast troponin-right within the care pathway supports ED imperatives in the diagnosis of acute coronary syndrome (ACS) with the enitirety of available clinical information.*
Patients with respiratory symptoms need rapid, accurate assessment to inform cohorting, admission, and treatment strategies.
Representing 9% of all non-injury ED visits, abdominal pain is the single most common complaint in the ED.2
Expediting diagnostic testing supports reduced turnaround time to help alleviate bottlenecks and treatment delays.
With sepsis patients, every minute matters. Accelerate sepsis response in your ED with fast, accurate results at the point of care.
Chest pain patients represent a diagnostic dilemma for the ED. Fast troponin-right within the care pathway supports ED imperatives in the diagnosis of acute coronary syndrome (ACS) with the enitirety of available clinical information.*
Patients with respiratory symptoms need rapid, accurate assessment to inform cohorting, admission, and treatment strategies.
Representing 9% of all non-injury ED visits, abdominal pain is the single most common complaint in the ED.2
Expediting diagnostic testing supports reduced turnaround time to help alleviate bottlenecks and treatment delays.
With sepsis patients, every minute matters. Accelerate sepsis response in your ED with fast, accurate results at the point of care.
Chest pain patients represent a diagnostic dilemma for the ED. Fast troponin-right within the care pathway supports ED imperatives in the diagnosis of acute coronary syndrome (ACS) with the enitirety of available clinical information.*
Patients with respiratory symptoms need rapid, accurate assessment to inform cohorting, admission, and treatment strategies.
The detection of a rise and/or fall of cardiac troponin plays a key role in the identification of patients suspected of having an Acute Coronary Syndrome (ACS) and earlier diagnosis of myocardial infarction.
Winter months and cold weather, in more than any other time of year, pose a greater risk to people suffering from new (acute) or ongoing (chronic) cardiac events.
*Medical decision should not be based on a single i-STAT measurement
A LEADER IN RAPID POINT-OF-CARE DIAGNOSTICS.
©2024 Abbott. All rights reserved. Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.
This website is governed by applicable U.S. laws and governmental regulations. The products and information contained herewith may not be accessible in all countries, and Abbott takes no responsibility for such information which may not comply with local country legal process, regulation, registration and usage.
Your use of this website and the information contained herein is subject to our Website Terms and Conditions and Privacy Policy. Photos displayed are for illustrative purposes only. Any person depicted in such photographs is a model. GDPR Statement
Not all products are available in all regions. Check with your local representative for availability in specific markets. For in vitro diagnostic use only. For i-STAT test cartridge information and intended use, refer to individual product pages or the cartridge information (CTI/IFU) in the i-STAT Support area.
Abbott - A Leader in Rapid Point-of-Care Diagnostics.
